219 related articles for article (PubMed ID: 20683902)
1. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
Bussard KM; Venzon DJ; Mastro AM
J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast cancer induces an osteoblast inflammatory response.
Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
[TBL] [Abstract][Full Text] [Related]
3. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
Chen YC; Sosnoski DM; Gandhi UH; Novinger LJ; Prabhu KS; Mastro AM
Carcinogenesis; 2009 Nov; 30(11):1941-8. PubMed ID: 19759193
[TBL] [Abstract][Full Text] [Related]
4. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
5. Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model.
Bodenstine TM; Beck BH; Cao X; Cook LM; Ismail A; Powers SJ; Powers JK; Mastro AM; Welch DR
Chin J Cancer; 2011 Mar; 30(3):189-96. PubMed ID: 21352696
[TBL] [Abstract][Full Text] [Related]
6. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
[TBL] [Abstract][Full Text] [Related]
7. Localization of osteoblast inflammatory cytokines MCP-1 and VEGF to the matrix of the trabecula of the femur, a target area for metastatic breast cancer cell colonization.
Bussard KM; Okita N; Sharkey N; Neuberger T; Webb A; Mastro AM
Clin Exp Metastasis; 2010 May; 27(5):331-40. PubMed ID: 20446021
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.
Mercer RR; Miyasaka C; Mastro AM
Clin Exp Metastasis; 2004; 21(5):427-35. PubMed ID: 15672867
[TBL] [Abstract][Full Text] [Related]
9. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.
Sosnoski DM; Norgard RJ; Grove CD; Foster SJ; Mastro AM
Clin Exp Metastasis; 2015 Apr; 32(4):335-44. PubMed ID: 25749879
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
Marino S; Bishop RT; Mollat P; Idris AI
Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
[TBL] [Abstract][Full Text] [Related]
11. Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts.
Liu X; Cao M; Palomares M; Wu X; Li A; Yan W; Fong MY; Chan WC; Wang SE
Breast Cancer Res; 2018 Oct; 20(1):127. PubMed ID: 30348200
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
[TBL] [Abstract][Full Text] [Related]
13. Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch.
Mulcrone PL; Campbell JP; Clément-Demange L; Anbinder AL; Merkel AR; Brekken RA; Sterling JA; Elefteriou F
J Bone Miner Res; 2017 Jul; 32(7):1442-1454. PubMed ID: 28300321
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of metastatic breast cancer cell trafficking in bone.
Phadke PA; Mercer RR; Harms JF; Jia Y; Frost AR; Jewell JL; Bussard KM; Nelson S; Moore C; Kappes JC; Gay CV; Mastro AM; Welch DR
Clin Cancer Res; 2006 Mar; 12(5):1431-40. PubMed ID: 16533765
[TBL] [Abstract][Full Text] [Related]
15. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
[TBL] [Abstract][Full Text] [Related]
16. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
Haider MT; Holen I; Dear TN; Hunter K; Brown HK
Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
[TBL] [Abstract][Full Text] [Related]
17. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
18. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
Morrissey C; Lai JS; Brown LG; Wang YC; Roudier MP; Coleman IM; Gulati R; Vakar-Lopez F; True LD; Corey E; Nelson PS; Vessella RL
Prostate; 2010 Mar; 70(4):412-24. PubMed ID: 19866469
[TBL] [Abstract][Full Text] [Related]
19. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
[TBL] [Abstract][Full Text] [Related]
20. MDA-MET-conditioned-medium augments the chemoattractant-dependent migration of MDA-MET cells towards hFOB-conditioned medium and increases collagenase activity.
Chin-Quee K; Donahue HJ
BMC Cancer; 2017 May; 17(1):324. PubMed ID: 28494752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
